Article
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
21 Apr 2010
Abstract excerpt
BACKGROUND: Neuroblastoma is a paediatric cancer of the sympathetic nervous system. The single most important genetic indicator of poor clinical outcome is amplification of the MYCN transcription factor. One of many down-stream MYCN targets is miR-184, which is either directly or indirectly repressed by this transcription factor, possibly due to its pro-apoptotic effects when ectopically over-expressed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
